AVID RADIOPHARMACEUTICALS, INC.

Address

AVID RADIOPHARMACEUTICALS, INC.
3624 Market Street, 5th Floor
Philadelphia, PA, 19104

Information

DUNS: 170631720
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of Radiopharmaceuticals for Imaging Brain Tau Pathology

    Amount: $498,812.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical m ...

    SBIRPhase I2008Department of Health and Human Services
  2. 18F-AV-133, A Novel Radiopharmaceutical for Differential Diagnosis of Dementia

    Amount: $498,750.00

    DESCRIPTION (provided by applicant): Dementia, with its most prevalent subforms Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia, is a very substantial medical and so ...

    SBIRPhase I2008Department of Health and Human Services
  3. 18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment

    Amount: $507,496.00

    DESCRIPTION (provided by applicant): Dementia associated with PD (PDD) is common (affecting up to 80% of patients long-term) and highly disabling. Informative biomarkers are urgently needed to underst ...

    SBIRPhase I2008Department of Health and Human Services
  4. Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's

    Amount: $250,000.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical ...

    STTRPhase I2007Department of Health and Human Services
  5. 18F-FP-DTBZ for PET Imaging of Beta Cell Mass in Diabetes

    Amount: $247,050.00

    DESCRIPTION (provided by applicant): Both Type I (T1D) and Type 2 (T2D) diabetes share a common pathophysiology - insufficient beta cell mass (BCM) to meet metabolic demands. Unfortunately, advances i ...

    SBIRPhase I2007Department of Health and Human Services
  6. AV1: F-18 Radiopharmaceutical for Imaging Amyloid Plaque

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Alzheimer's disease (AD). The project is driven by the hypothesis ...

    SBIRPhase I2005Department of Health and Human Services
  7. Radiopharmaceuticals for Imaging Brain Synuclein

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Dementia with Lewy Bodies (DLB). DLB is the second most common cau ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government